Case Report: Intercurrent infections in COVID-19-induced sustained immunodepression: is interferon gamma a suitable drug?

De Waard A, Lefebvre L, Textoris J, Payen D

Open source

DOI
10.3389/fimmu.2023.1183665
Published
2023
Container
Frontiers in immunology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2023.1183665,
  title = {Case Report: Intercurrent infections in COVID-19-induced sustained immunodepression: is interferon gamma a suitable drug?},
  author = {De Waard A and Lefebvre L and Textoris J and Payen D},
  year = {2023},
  journal = {Frontiers in immunology},
  doi = {10.3389/fimmu.2023.1183665},
  url = {https://doi.org/10.3389/fimmu.2023.1183665}
}

RIS

TY  - JOUR
TI  - Case Report: Intercurrent infections in COVID-19-induced sustained immunodepression: is interferon gamma a suitable drug?
AU  - De Waard A
AU  - Lefebvre L
AU  - Textoris J
AU  - Payen D
PY  - 2023
JO  - Frontiers in immunology
DO  - 10.3389/fimmu.2023.1183665
UR  - https://doi.org/10.3389/fimmu.2023.1183665
ER  - 

APA

A, D. W., L, L., J, T., & D, P. (2023). Case Report: Intercurrent infections in COVID-19-induced sustained immunodepression: is interferon gamma a suitable drug?. Frontiers in immunology. https://doi.org/10.3389/fimmu.2023.1183665

Source records